Literature DB >> 6156734

The effects of sensory denervation on the responses of the rabbit eye to prostaglandin E1, bradykinin and substance P.

J M Butler, B R Hammond.   

Abstract

1 Six to eight days after diathermic destruction of the fifth cranial nerve in the rabbit, the ocular hypertensive and miotic responses to intracameral administration of capsaicin, bradykinin, and prostaglandin E1 were greatly reduced or completely abolished. The response to substance P was not abolished. 2 A response could still be obtained to chemical irritants 36 h after coagulation of the nerve and it is deduced that manifestation of the response is dependent upon functional sensory nerve terminals, and is independent of central connections. 3 It is suggested that prostaglandin E1 and bradykinin act directly upon the sensory nerve endings and that propagation of the response is augmented by axon reflex. 4 In view of the ability of substance P to induce miosis in the denervated eyes, it is presumed that its actions are not mediated via sensory nerves. 5 It is considered possible that the mediator(s) released from sensory nerve endings after chemical irritation or antidromic stimulation may act in the same way as substance P with regard to the miotic effect. 6 Synthetic substance P will only produce ocular hypertension in doses which induce a maximal miotic response. This may either be a question of access or a partial resemblance to the endogenous mediator.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156734      PMCID: PMC2044277          DOI: 10.1111/j.1476-5381.1980.tb07040.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Neurohumoral features of afferent fibers in man. Their role in vasodilation, inflammation, and pain.

Authors:  L F CHAPMAN; A O RAMOS; H GOODELL; H G WOLFF
Journal:  Arch Neurol       Date:  1961-06

2.  [Central transmission of afferent impulses. III. Incidence and significance of the substance P in the dorsal roots of the spinal cord].

Authors:  F LEMBECK
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1953

3.  Further researches on antidromic nerve-impulses.

Authors:  W M Bayliss
Journal:  J Physiol       Date:  1902-07-21       Impact factor: 5.182

4.  On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb, and on the nature of these fibres.

Authors:  W M Bayliss
Journal:  J Physiol       Date:  1901-02-28       Impact factor: 5.182

5.  Prostaglandin and nerve-mediated response of the rabbit eye to argon laser irradiation of the iris.

Authors:  W G Unger; M S Bass
Journal:  Ophthalmologica       Date:  1977       Impact factor: 3.250

6.  The mechanism of antidromic vasodilatation.

Authors:  F D IBRAHIM; G STELLA; M TALAAT
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1951

7.  Prostaglandins and the eye.

Authors:  E S Perkins
Journal:  Adv Ophthalmol       Date:  1975

8.  The site of breakdown of the blood-aqueous barrier under the influence of vaso-dilator drugs.

Authors:  D F Cole
Journal:  Exp Eye Res       Date:  1974-12       Impact factor: 3.467

9.  Sensory mediation of the ocular response to neutral formaldehyde.

Authors:  J M Butler; W G Unger; B R Hammond
Journal:  Exp Eye Res       Date:  1979-05       Impact factor: 3.467

10.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin.

Authors:  N Jancsó; A Jancsó-Gábor; J Szolcsányi
Journal:  Br J Pharmacol Chemother       Date:  1967-09
View more
  20 in total

1.  Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart.

Authors:  P Geppetti; C A Maggi; F Perretti; S Frilli; S Manzini
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  Ocular responses evoked by capsaicin and prostaglandin E2 are inhibited by a substance P antagonist.

Authors:  G Bynke; R Håkanson; J Hörig
Journal:  Experientia       Date:  1983-09-15

3.  International Substance P Symposium. Dublin, April 27-29, 1983. Abstracts.

Authors: 
Journal:  Ir J Med Sci       Date:  1983       Impact factor: 1.568

4.  Mapping, quantitative distribution and origin of substance p- and VIP-containing nerves in the uvea of guinea pig eye.

Authors:  G Terenghi; J M Polak; L Probert; G P McGregor; G L Ferri; M A Blank; J M Butler; W G Unger; S Zhang; D F Cole; S R Bloom
Journal:  Histochemistry       Date:  1982

5.  Role of substance P in the antidromic vasodilation, neurogenic plasma extravasation and disruption of the blood-aqueous barrier in the rabbit eye.

Authors:  J Stjernschantz; M Sears; H Mishima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

6.  Substance P-immunoreactive nerve fibres in the anterior segment of the rabbit eye. Distribution and possible physiological significance.

Authors:  K Tornqvist; A Mandahl; S Leander; I Lorén; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

7.  Shigella endotoxin-induced ocular inflammation in the normal and sensory denervated rabbit eye.

Authors:  W G Unger; J M Butler; E E Morsi
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

8.  Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells.

Authors:  J Nardone; C Gerald; L Rimawi; L Song; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

10.  Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit.

Authors:  T Griesbacher; F Lembeck
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.